QUYEN NGUYEN: Open Payments
NPI 1710006176 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 10 payments from 7 companies in 2025. Trend: 2023 $146 · 2024 $886 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $310 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $103 |
| ABBVIE INC. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| AtriCure, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| CONMED Corporation | 1 | $15 |
Products named: KRYSTEXXA, TAVNEOS, ENTYVIO, ATRICLIP LAA EXCLUSION SYSTEM, VIVITROL, CREON, LINZESS, VISICLEAR.
Industry payments across CA — which companies pay providers there.
